Evidence map›Paper›PMID 26386725›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.

Xianglan Zhang, Im-Hee Jung, Young Sun Hwang

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Xianglan ZhangOral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea.
Im-Hee JungDepartment of Dental Hygiene, College of Health Science, Eulji University, Seongnam, Republic of Korea.
Young Sun HwangDepartment of Dental Hygiene, College of Health Science, Eulji University, Seongnam, Republic of Korea. kiteys@eulji.ac.kr.
Eulji University · KRYanbian University Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The initiation and progression of cancer is closely associated with the tumor microenvironment. The overexpression of oncogenes during tumor growth and progression by stromal stimuli can affect the aggressiveness of the cancer. In this study, in vitro and in vivo studies were performed to examine the role of stromal epidermal growth factor (EGF) in enhancing the invasive potential of in low-invasive cancer. EGF was tested in order to elucidate the specific molecules that participate in increasing the invasive potential of low-invasive cancer cells. EGF stimulation enhanced cancer invasion in an EGF receptor (EGFR)-dependent manner. EGF induced insulin-like growth factor-II mRNA-binding protein-3 (IMP-3) and podoplanin (PDPN) expression, which play an important role in oral squamous cell carcinoma (OSCC) cell invasion. An apparent tumor mass was not observed in the mouse xenograft; however, multiple tumor microfoci were seen in mice injected with IMP-3-overexpressing cells. These results show that EGF stimulates IMP-3 expression, thereby increasing cancer invasion and tumor progression.

Indexed as

AnimalsCarcinoma, Squamous CellCell Line, TumorEpidermal Growth FactorErbB ReceptorsHumansMaleMiceMice, Inbred BALB CMouth NeoplasmsNeoplasm InvasivenessRNA-Binding ProteinsRNA, MessengerTumor MicroenvironmentEpidermal Growth FactorErbB ReceptorsIGF2BP3 protein, humanRNA-Binding ProteinsRNA, MessengerEpidermal growth factorIMP-3InvasionPDPNStroma

Identifiers

PMID26386725
OpenAlexW1648644107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.